PMID- 8634418 OWN - NLM STAT- MEDLINE DCOM- 19960710 LR - 20210216 IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 87 IP - 5 DP - 1996 Mar 1 TI - The RAR-RXR as well as the RXR-RXR pathway is involved in signaling growth inhibition of human CD34+ erythroid progenitor cells. PG - 1728-36 AB - Previous studies have shown that retinoic acid (RA), similar to tumor necrosis factor-alpha (TNF-alpha), can act as a bifunctional regulator of the growth of bone marrow progenitors, in that it can stimulate granulocyte-macrophage colony-stimulating factor (GM-CSF)- or interleukin-3 (IL-3)-induced GM colony formation, but potently inhibit G-CSF-induced growth. The present study, using highly enriched human CD34+ as well as Lin- murine bone marrow progenitor cells, demonstrates a potent inhibitory effect of 9-cis-RA on burst-forming unit-erythroid (BFU-E) colony formation regardless of the cytokine stimulating growth. Specifically, 9-cis-RA potently inhibited the growth of BFU-E response to erythropoietin (Epo) (100%), stem cell factor (SCF) + Epo (92%), IL-3 + Epo (97%), IL-4 + Epo (88%), and IL-9 + Epo (100%). Erythroid colony growth was also inhibited when CD34+ progenitors were seeded at one cell per well, suggesting a direct action of RA. Using synthetic ligands to retinoic acid receptors (RARs) and retinoid X receptors (RXRs) that selectively bind and activate RAR-RXR or RXR-RXR dimers, respectively, we dissected the involvement of the two retinoid response pathways in the regulation of normal myeloid and erythroid progenitor cell growth. Transactivation studies showed that both the RAR (Ro 13-7410) and RXR (Ro 25-6603 and Ro 25-7386) ligands were highly selective at 100 nmol/L. At this concentration, Ro 13-7410 potently inhibited G-CSF-stimulated myeloid as well as SCF + Epo-induced erythroid colony growth. At the same concentration, Ro 25-6603 and Ro 25-7386 had little or no effect on G-CSF-induced colony formation, whereas they inhibited 75% and 53%, respectively, of SCF + Epo-stimulated BFU-E colony growth. Thus, the RAR-RXR response pathway can signal growth inhibition of normal bone marrow myeloid and erythroid progenitor cells. In addition, we demonstrate a unique involvement of the RXR-RXR pathway in mediating growth inhibition of erythroid but not myeloid progenitor cells. FAU - Rusten, L S AU - Rusten LS AD - Department of Immunology, Institute for Cancer Research, The Norweigian Radium Hospital, Oslo. FAU - Dybedal, I AU - Dybedal I FAU - Blomhoff, H K AU - Blomhoff HK FAU - Blomhoff, R AU - Blomhoff R FAU - Smeland, E B AU - Smeland EB FAU - Jacobsen, S E AU - Jacobsen SE LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Antigens, CD34) RN - 0 (Benzoates) RN - 0 (Cyclohexanes) RN - 0 (Hematopoietic Cell Growth Factors) RN - 0 (Interleukins) RN - 0 (Pentanoic Acids) RN - 0 (RARA protein, human) RN - 0 (Rara protein, mouse) RN - 0 (Rara protein, rat) RN - 0 (Receptors, Retinoic Acid) RN - 0 (Recombinant Proteins) RN - 0 (Retinoic Acid Receptor alpha) RN - 0 (Retinoid X Receptors) RN - 0 (Retinoids) RN - 0 (Ro 25-6603) RN - 0 (Stem Cell Factor) RN - 0 (Transcription Factors) RN - 11096-26-7 (Erythropoietin) RN - 5688UTC01R (Tretinoin) RN - 71441-28-6 (4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid) SB - IM MH - Animals MH - Antigens, CD34 MH - Base Sequence MH - Benzoates/pharmacology MH - Consensus Sequence MH - Cyclohexanes/pharmacology MH - Depression, Chemical MH - Erythroid Precursor Cells/*cytology/drug effects MH - Erythropoiesis/*drug effects MH - Erythropoietin/pharmacology MH - Hematopoietic Cell Growth Factors/pharmacology MH - Humans MH - Interleukins/pharmacology MH - Mice MH - Mice, Inbred BALB C MH - Molecular Sequence Data MH - Pentanoic Acids/pharmacology MH - Rats MH - Receptors, Retinoic Acid/agonists/drug effects/*physiology MH - Recombinant Proteins/pharmacology MH - Retinoic Acid Receptor alpha MH - Retinoid X Receptors MH - Retinoids/pharmacology MH - Signal Transduction/*physiology MH - Stem Cell Factor/pharmacology MH - Transcription Factors/drug effects/*physiology MH - Tretinoin/pharmacology EDAT- 1996/03/01 00:00 MHDA- 1996/03/01 00:01 CRDT- 1996/03/01 00:00 PHST- 1996/03/01 00:00 [pubmed] PHST- 1996/03/01 00:01 [medline] PHST- 1996/03/01 00:00 [entrez] AID - S0006-4971(20)65280-6 [pii] PST - ppublish SO - Blood. 1996 Mar 1;87(5):1728-36.